News
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second-quarter 2025 investor letter.
StockStory.org on MSN14h
Upwork (NASDAQ:UPWK) Reports Strong Q2, Stock Jumps 12.3%
Online work marketplace Upwork (NASDAQ:UPWK) reported Q2 CY2025 results , but sales were flat year on year at $194.9 million.
30m
MT Newswires on MSNHut 8 Up 1.6% in Nasdaq Pre-market After Swing to Q2 Profit
Hut 8 (HUT.TO) traded 1.6% higher at last look Thursday in Nasdaq pre-market trading as it exceeded analysts' expectations after swinging to a net profit in the second quarter. The energy ...
StockStory.org on MSN13h
DraftKings (NASDAQ:DKNG) Surprises With Q2 Sales, Stock Soars
Fantasy sports and betting company DraftKings (NASDAQ:DKNG) announced in Q2 CY2025, with sales up 36.9% year on year to $1.51 ...
StockStory.org on MSN12h
Allient’s (NASDAQ:ALNT) Q2: Strong Sales, Stock Jumps 18.9%
Precision motion systems specialist Allient (NASDAQ:ALNT) reported in Q2 CY2025, with sales up 2.6% year on year to $139.6 ...
StockStory.org on MSN14h
AerSale (NASDAQ:ASLE) Beats Expectations in Strong Q2, Stock Jumps 19.1%
Aerospace and defense company AerSale (NASDAQ:ASLE) reported Q2 CY2025 results , with sales up 39.3% year on year to $107.4 ...
StockStory.org on MSN15h
Duolingo (NASDAQ:DUOL) Surprises With Q2 Sales, Stock Jumps 10.8%
Language-learning app Duolingo (NASDAQ:DUOL) reported Q2 CY2025 results , with sales up 41.5% year on year to $252.3 million.
StockStory.org on MSN15h
Sunrun (NASDAQ:RUN) Reports Upbeat Q2, Stock Jumps 15.4%
Residential solar energy company Sunrun (NASDAQ:RUN) reported in Q2 CY2025, with sales up 8.7% year on year to $569.3 million ...
StockStory.org on MSN15h
GoodRx (NASDAQ:GDRX) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops
Healthcare tech company GoodRx (NASDAQ:GDRX) in Q2 CY2025 as sales only rose 1.2% year on year to $203.1 million. Its ...
StockStory.org on MSN14h
Exact Sciences (NASDAQ:EXAS) Reports Strong Q2 But Stock Drops 15.2%
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported Q2 CY2025 results , with sales up 16% year on year to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results